Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
LumiraDX Goes Public In SPAC Merger
30 Sep 2021
•
By
Barnaby Pickering
Investors have been wary of LuminaraDX since its placement on NASDAQ, driving the share price down.
LumiraDX's testing protocol, featuring its central device. • Source: LumiraDX
More from Financing
More from Business